Search company, investor...

Founded Year

2018

Stage

Seed VC | Alive

Total Raised

$500K

Last Raised

$500K | 4 yrs ago

About OculoMotor Technologies

OculoMotor Technologies' mission is to bring technological advances to optometrists and vision therapists, enabling them to provide improved clinical outcomes and engaging therapeutic experiences to patients with binocular vision disorders. OMT enables optometrists to increase revenues by integrating research-backed virtual reality assessments and therapies into their existing workflows.

Headquarters Location

323 MLK Blvd

Newark, New Jersey, 07102,

United States

Loading...

Loading...

Expert Collections containing OculoMotor Technologies

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

OculoMotor Technologies is included in 2 Expert Collections, including AR/VR.

A

AR/VR

1,437 items

This collection includes companies creating hardware and/or software for augmented reality, virtual reality, and mixed reality applications.

D

Digital Health

10,585 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

OculoMotor Technologies Frequently Asked Questions (FAQ)

  • When was OculoMotor Technologies founded?

    OculoMotor Technologies was founded in 2018.

  • Where is OculoMotor Technologies's headquarters?

    OculoMotor Technologies's headquarters is located at 323 MLK Blvd, Newark.

  • What is OculoMotor Technologies's latest funding round?

    OculoMotor Technologies's latest funding round is Seed VC.

  • How much did OculoMotor Technologies raise?

    OculoMotor Technologies raised a total of $500K.

  • Who are the investors of OculoMotor Technologies?

    Investors of OculoMotor Technologies include Foundation Venture Capital Group.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.